Trials / Completed
CompletedNCT01350791
Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT )
Evaluation of Effectiveness and Safety of PROMUS Element™ in Routine Clinical Practice; A Multicenter, PROSPECTIVE OBSERVATIONAL STUDY
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,001 (actual)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a non-randomized, prospective, open-label registry to compare the efficacy and safety of Promus Element stents versus first-generation drug-eluting stent (DES) in patients with coronary artery disease.
Detailed description
The Element Stent platform features a proprietary Platinum Chromium Alloy, designed specifically for coronary stents. This alloy, coupled with a new stent architecture, is designed to enable thinner struts, increased flexibility and a lower profile while improving radial strength, recoil and visibility. In addition, the PROMUS Element Stent System incorporates the new Apex™ Dilatation Catheter technology, designed to enhance deliverability to complex lesions. Currently, there have been limited data regarding comparison of PROMUS Element stent with first-generation DES in routine clinical practice. Therefore, we perform large-scale real-world registry of PROMUS Element stents.
Conditions
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2013-10-01
- Completion
- 2016-12-01
- First posted
- 2011-05-10
- Last updated
- 2017-07-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01350791. Inclusion in this directory is not an endorsement.